Respecting patient autonomy while seeking to understand patients’ unique perspectives can strengthen patient-surgeon relationships.

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"

Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity.

Drawing on the film Wonder, this article examines how a narrative of community acceptance offers sustaining relationships for people with unusual facial appearance.

Mandating processes that are not evidence based generates distress among patients and clinicians, so physician advocacy in national, state, and local policymaking is key.

Dr Kristen N. Pallok joins Ethics Talk to discuss her article, coauthored with Dr David A. Ansell: “Should Clinicians Be Activists?”

The total concentration, power tools, and high stakes of the OR provided an exciting escape from the world I was supposed to occupy and from which I was supposed to derive my deepest satisfaction as a woman.

Efforts to meet the demand for organs have long had disproportionate effects on members of particular races, not only because of disparate levels of need for transplants but because of the way our donation system works.